Art

J-GLOBAL ID：201802249345519520   Reference number：18A1469951

Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials

関節リウマチを有する日本人患者におけるバリシチニブの有効性および安全性:4か国第3相無作為化試験のサブグループ分析

Author (9)： TANAKA Yoshiya (Univ. Occupational and Environmental Health, Kitakyushu, JPN) ,  ATSUMI Tatsuya (Hokkaido Univ., Hokkaido, JPN) ,  AMANO Koichi (Saitama Medical Univ., Kawagoe, JPN) ,  HARIGAI Masayoshi (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  ISHII Taeko (Eli Lilly Japan K.K., Kobe, JPN) ,  KAWAGUCHI Osamu (Eli Lilly Japan K.K., Kobe, JPN) ,  ROONEY Terence P. (Eli Lilly and Co., IN, USA) ,  AKASHI Naotsugu (Eli Lilly Japan K.K., Kobe, JPN) ,  TAKEUCHI Tsutomu (Keio Univ. School of Medicine, Tokyo, JPN)
Material： Modern Rheumatology  (Mod Rheumatol)
Volume： 28  Issue： 4  Page： 583-591  Publication year： Jul. 2018 
JST Material Number： L5142A  ISSN： 1439-7595  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： rate of effect ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1469951&from=J-GLOBAL&jstjournalNo=L5142A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D)

Substance index (2)： Baricitinib ,  Methotrexate

Reference (26)：

• MTX clinical practice guidelines development subcommittee, Japan College of Rheumatology. Methotrexate (MTX) in the treatment of rheumatoid arthritis: clinical practice guidelines, 2011 edition (in Japanese). Available from: http://www.ryumachi-jp.com/info/img/MTX2011kanni.pdf [last assessed 24 Apr 2017].
• Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheum. 2016;68:1-26.
• European Medicines Agency. Guideline on clinical investigation of medicinal products other than NSAIDS for treatment of rheumatoid arthritis (draft); 2015. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/06/WC500187583.pdf [last accessed 24 Apr 2017].
• Koike R, Takeuchi T, Eguchi K, Miyasaka N. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol. 2007;17:451-8.
• Koike T, Harigai M, Ishiguro N, Inokuma S, Takei S, Takeuchi T, et al. Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients. Mod Rheumatol. 2012;22:498-508.

Terms in the title (9)： 関節リウマチ ,  日本人 ,  患者 ,  バリシチニブ ,  安全性 ,  3相 ,  無作為化試験 ,  サブ ,  グループ分析